The Rise of The “Metasite” in Decentralized Clinical Trials
Decentralized clinical trials are at a pivotal juncture, shaped by technological advancements and evolving regulatory landscapes. While traditional clinical...
Moe Alsumidaie
Decentralized Clinical Trials: How the FDA is Supporting its Growth
As the clinical trials industry embraces change, Decentralized Clinical Trials (DCTs) are emerging as the next significant evolution. Marrying...
Navigating Compassionate Use in Clinical Research: Unpacking FDA’s Latest Guidance
Compassionate use, also known as expanded access, is a critical pathway for patients with life-threatening conditions to access investigational...
How to Harness Data Science to Predict Clinical Trial Outcomes
In today’s world, where data drives many decisions, the biopharmaceutical industry is no exception. Integrating data science into clinical...
Are Clinical Research Sites Just Whiners or Genuine Victims?
In recent times, LinkedIn has transformed from a platform for professional networking to a sounding board for industry grievances....
CTMS BOT: A New Tool for Clinical Trial Automation
In the realm of clinical studies, the nuances and enormous datasets necessitate utmost precision, swift actions, and efficiency. Astellas,...
Patient Engagement Scores: How Do Different Therapeutic Areas Compare?
The value of patient-centric approaches has never been more evident in clinical trials. The FDA encourages patient engagement in...
How MERIS Total Engagement Solution is Ushering in a New Era of Transparency in Patient Recruitment
In the rapidly evolving landscape of clinical trial patient recruitment, the challenges of patient recruitment, patient retention, and data...
Pharma R&D and GxP Quality Assurance Can Be Improved by AI
The rapidly evolving field of artificial intelligence (AI) and data analytics offers immense potential for enhancing clinical trial quality...